Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,588 | -97,172 | -77,872 | -52,293 | -25,473 |
| Depreciation Amortization | 33 | 168 | 126 | 86 | 43 |
| Accounts payable and accrued liabilities | 1,091 | 1,237 | -927 | -896 | -2,083 |
| Other Working Capital | 10,637 | 1,838 | 3,510 | 1,773 | 1,559 |
| Other Operating Activity | 3,526 | 8,123 | 8,638 | 4,945 | 4,178 |
| Operating Cash Flow | $-17,301 | $-85,806 | $-66,525 | $-46,385 | $-21,776 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -161 | -150 | -83 | -47 |
| Investing Cash Flow | $-2 | $-161 | $-150 | $-83 | $-47 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 187,265 | 182 | 123 | 123 | N/A |
| Other Financing Activity | 1,377 | 65,395 | 65,395 | 65,395 | 0 |
| Financing Cash Flow | $188,642 | $65,577 | $65,518 | $65,518 | $0 |
| Exchange Rate Effect | -193 | 205 | 621 | 592 | 459 |
| Beginning Cash Position | 15,483 | 35,668 | 35,668 | 35,668 | 35,668 |
| End Cash Position | 186,629 | 15,483 | 35,132 | 55,310 | 14,304 |
| Net Cash Flow | $171,146 | $-20,185 | $-536 | $19,642 | $-21,364 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,301 | -85,806 | -66,525 | -46,385 | -21,776 |
| Capital Expenditure | -2 | -161 | -150 | -83 | -47 |
| Free Cash Flow | -17,303 | -85,967 | -66,675 | -46,468 | -21,823 |